MicroDose Therapeutx, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1998-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://mdtx.com
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 10
- Registration Number
- NCT01556607
- Locations
- 🇺🇸
West Coast Clinical Trials, Costa Mesa, California, United States
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers
- First Posted Date
- 2011-12-09
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 36
- Registration Number
- NCT01489306
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Drug SafetyRespiratory Syncytial Virus Infections
- Interventions
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2012-04-12
- Lead Sponsor
- MicroDose Therapeutx, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT01355016
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
© Copyright 2025. All Rights Reserved by MedPath